4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-22-004327
CHIEF EXECUTIVE OFFICER bought 30,000 shares at $2.29 ($68,700)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2022-06-13 | Purchase | +30,000 | $2.29 | $68,700 | 5,291,873 | D |
| Open-market purchases · 30,000 sh · avg $2.29 · $68,700 | |||||||
Loading xslF345X03/ownership.xml…